cost-saving. There is, in fact, good evidence that while smoking cessation may reduce health care spending over the medium term, in the longer term (15 to 30 years) health care spending is actually increased.
The explanation for this is perfectly simple: nonsmokers live longer and therefore incur expensive health care costs in old age. These additional costs exceed the lower expenditures of earlier years. Quite apart from increased health care spending there would be two additional negative effects on government finances if all smokers quit: Governments would lose the hefty revenues generated by tobacco taxes, and there would be increased spending on pension payments.
This argument appeared in an analysis carried out by the British government in 1971. The report was never officially published but was leaked in 1980. 3, 4 What applies to smoking also applies in other scenarios: the prevention of fatal diseases actually leads to an increase in health care spending. 5 Indeed, our best evidence is that most medical interventions designed to prevent disease or improve health cause an increase in health care spending. 6 Of course, the prevention of fatal diseases is undeniably of great value with regard to population health and should therefore be strongly supported. Moreover, prevention can often be much more cost-effective than many medical treatments. 7 However, this is altogether different from decreasing health care spending.
Polio immunity in Ontario
With reference to the article by King, 1 the population in Ontario cannot be considered to be fully immune to poliomyelitis when one considers the immune status of people 60 years of age and older. In all probability these individuals were never vaccinated against poliomyelitis during their infancy, childhood or adolescence. The vaccines were not available before 1960.
Such people could become infected with paralytic poliomyelitis if they were exposed to wild, live or vaccinederived strains in the event of any importation and dissemination of the That's not good enough. These studies show that children and teens have significant insufficiency. Addressing osteoporosis early will influence peak bone mass and result in stronger bones for the future.
Supplementation with 2000 IU of vitamin D 3 in an institutionalized group (tested after a minimum of five months of supplementation) did not result in toxicity and did not achieve normal levels for everyone (94% > 80 nmol/L). 3 The use of 2000 IU in the first year of life reduced the risk of developing type 1 diabetes over the next 30 years. 4 There is emerging evidence of the benefit of vitamin D in the immune system for oral health, tuberculosis, influenza, hepatitis C, eczema, woundhealing, etc. Vitamin D levels required may be significantly higher than 75 nmol/L. hydraSense ® relieves nasal and sinus congestion by facilitating blowing of the nose, helping to reduce the risk of upper respiratory infections such as sinusitis.
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